![N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide](https://static.cymitquimica.com/products/3D/img/FC145515.png "Cliquez pour agrandir")
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
CAS : 59831-65-1
Ref. 3D-FC145515
| 1mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté |
Informations sur le produit
Nom :
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
Synonymes :
- Halopemide
- 59831-65-1
- N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide
- N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide
Description :
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide (NFA) is a novel benzodiazepine receptor inverse agonist that has been shown to be a potent inhibitor of fatty acid synthase in vitro and in vivo. NFA has been shown to inhibit the production of gamma aminobutyric acid (GABA) with an IC50 value of 0.8 nM. This drug binds to the GABA receptor with high affinity and inhibits the binding of GABA, which is responsible for its anti-anxiety effects. NFA also blocks the binding of dopamine and other drugs to their receptors, which may contribute to its antidepressant properties.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
416.88 g/mol
Formule :
C21H22ClFN4O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
